Ultragreen Ai Ltd
Company Profile
Business description
Ultragreen Ai Ltd operates in the fluorescence-guided surgery (FGS) sector and develops vertical AI tools that use data-driven fluorescence imaging solutions for surgical applications. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the majority of its revenue from the DxG - Americas segment, which focuses on the sales of ICG vials and related pharmaceutical products.
Contact
463 MacPherson Road
No. 06-00, M463
Singapore368181
SGPT: +65 98172903
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
Undervalued ASX retailer benefiting from rebound in spending
stocks
Undervalued ASX share searches for cost savings
stocks
Chart of the Week: Where we see opportunities after year end market sell-off
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,963.00 | 8.60 | 0.10% |
| CAC 40 | 8,085.76 | 63.07 | 0.79% |
| DAX 40 | 24,294.61 | 164.47 | 0.68% |
| Dow JONES (US) | 48,704.01 | 646.26 | 1.34% |
| FTSE 100 | 9,703.16 | 47.63 | 0.49% |
| HKSE | 25,530.51 | 10.27 | -0.04% |
| NASDAQ | 23,593.86 | 60.30 | -0.25% |
| Nikkei 225 | 50,148.82 | 453.98 | -0.90% |
| NZX 50 Index | 13,452.24 | 56.37 | 0.42% |
| S&P 500 | 6,901.00 | 14.32 | 0.21% |
| S&P/ASX 200 | 8,673.40 | 8.50 | 0.10% |
| SSE Composite Index | 3,873.32 | 27.18 | -0.70% |